Track the Lifeward Ltd. stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €21.2m. The latest transaction was filed on 28 August 2026 (Attribution). Among the most active insiders: Swinford Michael. Every trade is free.
23
Insider Decl.
n/a
Thresholds
€109,544
4 ops.
Buy Volume
€261,119
5 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Lifeward Ltd. Strong Buy (bullish), based on 2 analysts. Average price target: US$20.00.
35Σ signal
Buys €109,544€261,119 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,428 of 29,056 companies
10.2
score / 100
Value
2
Quality
18
FCF yld-80%
Earn yld-94%
EV/EBITDA·
ROE-226%
Gross mgn38%
Net mgn-90%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
2,672 shares@ US$3.256100.0% of flowOrdinary Shares, par value NIS 1.75 per shareSEC:0001062993-24-016656:0
23 of 23 declarations
About Lifeward Ltd.
Lifeward Ltd. is a company listed on the XNAS market, specializing in the development of innovative solutions for the healthcare sector. It focuses on enhancing patient quality of life through advanced technologies.